In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study

European Journal of Pharmacology

Volumn 313, Issue 1-2, 1996, Pages 63-67

  Cagnotto, Alfredo ^a   Parotti, Luca ^a   Mennini, Tiziana ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Autoradiography; Dopamine receptor; Piribedil

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; PIRIBEDIL; RECEPTOR SUBTYPE; SPIPERONE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0030579086     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00503-1     Document Type: Article

References (19)

1. 3 receptor ligand, Eur. J. Pharmacol. 249, R9.
2. De Lean, A., P.J. Munson and D. Rodbard, 1978, Simultaneous analysis of families of sigmoidal curves: applications to bioassay, radioligand assay and physiological dose-response curves, Am. J. Physiol. 235, E97.
3. Diaz, J., D. Lévesque, C.H. Lammers, N. Griffon, M.P. Martres, J.C. Schwartz and P. Sokoloff, 1995, Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain, Neuroscience 65, 731.
4. Dourish, C.T., 1983, Piribedil: behavioural, neurochemical and clinical profile of dopamine agonist, Prog. Neuropsychopharmacol. Biol. Psychiatry 7, 3.
5. 3H-N,n-propyl norapomorphine, Eur. J. Pharmacol. 87, 85.
6. Jenner, P., 1992, Parkinson's disease: pathological mechanism and actions of piribedil, J. Neurol. 239 (Suppl. 1), S2.
7. 3 receptor site in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography, Eur. J. Neurosci. 5, 145.
8. 3 receptors, Eur. J. Pharmacol. 278, 243.
9. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. USA 89, 8155.
10. Miller, R.J. and L.L. Iversen, 1974, Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495), Naunyn-Schmiedeberg's Arch. Pharmacol. 282. 213.
11. 2 receptors elicits prolactin secretion and catalepsy, J. Pharmacol. Exp. Ther. 275, 885.
12. 2 receptors, Neuroscience 36, 403.
13. Paxinos, G. and C. Watson, 1982, The Rat Brain in Stereotaxic Coordinates (Academic Press, San Diego).
14. Rondot, P. and M. Ziegler, 1992, Activity and acceptability of piribedil in Parkinson's disease: a multicentre study, J. Neurol. 239 (Suppl. 1), S28.
15. Sarati, S., G. Guiso, S. Garattini and S. Caccia, 1991, Kinetics of piribedil and effects on dopamine metabolism: hepatic biotransformation is not a determinant of its dopaminergic action in rats, Psychopharmacology 105, 541.
16. 3 receptors and σ sites in the bovine caudate nucleus, Eur. J. Pharmacol. 242, R1.
17. 3) as target for neuroleptics, Nature (London) 347, 146.
18. 4 receptor with high affinity for the antipsychotic clozapine, Nature (London) 350, 610.
19. 3H]propyl-2-aminotetralin and carbetapentane, J. Neurochem. 64, 700.